|1.||Aaby, Peter: 13 articles (11/2015 - 06/2003)|
|2.||Rodrigues, Amabelia: 10 articles (11/2015 - 01/2007)|
|3.||Benn, Christine Stabell: 10 articles (11/2015 - 01/2007)|
|4.||Ravn, Henrik: 7 articles (11/2015 - 03/2007)|
|5.||Slusarczyk, Janusz: 7 articles (01/2007 - 01/2003)|
|6.||Gzyl, Anna: 7 articles (01/2007 - 01/2003)|
|7.||Augustynowicz, Ewa: 7 articles (01/2007 - 01/2003)|
|8.||Centers for Disease Control and Prevention (CDC): 6 articles (11/2014 - 10/2006)|
|9.||Gniadek, Grzegorz: 6 articles (09/2004 - 01/2003)|
|10.||Nielsen, Jens: 5 articles (11/2012 - 01/2007)|
|1.||Whooping Cough (Pertussis)
01/01/2009 - "A Japanese DPT vaccine dose of 0.2 mL thus proved effective against pertussis in adults."
05/01/1990 - "The point estimate of protective efficacy of the acellular DTP vaccine against typical pertussis was (6/10 - 1/9)/(6/10) x 100 = 81%. "
10/01/1998 - "We analyzed vaccine efficacy of an acellular pertussis component DTP vaccine (DTaP) and a whole cell pertussis component DTP vaccine (DTP) by compliance category. "
01/01/1992 - "[Improvement in the laboratory methods of assessing the safety of the of the pertussis component of DPT vaccine adsorbed]."
11/01/2013 - "[Preclinical studies of an adsorbed diphtheria-tetanus-pertussis vaccine (ADTP-vaccine) with acellular pertussis component]."
11/01/1997 - "Full protection against tetanus (titers > 0.1 IU/ml) was observed in the group of adults (0.37 IU/ml), in mothers (4.4 IU/ml) and their newborn offspring (5.5 IU/ml), and in children after receiving the second dose of DTP vaccine (1.86 IU/ml). "
05/01/2002 - "To assess the immunogenicity and reactogenicity of a tetanus conjugate Haemophilus influenzae type b vaccine (Act-Hib) when extemporaneously mixed and administered as a DTwP-Hib combination using an Indian DTwP vaccine (BE DTwP) in comparison with a licensed DTwP-Hib combination vaccine. "
09/01/1996 - "Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy."
02/05/1992 - "Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine."
10/01/1991 - "Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants."
05/01/1987 - "Besides, the study has shown that after the main complex of immunizations with adsorbed DPT vaccine protective immunity to diphtheria is retained in 90.3-96.8% of children covered by this study for 9-10 years. "
05/01/2007 - "The coverage rate of DPT vaccine did not necessarily reflect the immunity against diphtheria, suggesting the increase of immunity against diphtheria an urgent task to be taken care of."
06/01/1983 - "[Seroepidemiological survey of diphtheria in Thailand and the effect of a triple vaccine (DTP)]."
06/01/1981 - " Although 4 doses of DPT vaccine are not an absolute guarantee diphtheria will not occur, there are significant differences between vaccinated and unvaccinated children in the relative incidence, morbidity, and mortality from the disease. "
08/01/1979 - "The diphtheria component of adsorbed DPT vaccine seemed to be unable to ensure the sufficient level and intensity of immunity under conditions of a sharply decreased risk of encounter with the infective agent. "
07/01/1962 - "Studies on combined adsorbed poliomyelitis-DTP vaccine. "
09/01/2014 - "High dropout rates in the uptake of oral polio vaccine (OPV) and DTP vaccine persist despite efforts to improve immunisation coverage. "
01/01/2012 - "The rates by individual vaccine were similar across townships (p >0.05), except for diphtheria/tetanus/pertussis vaccine (p=0.02) and oral polio vaccine (p <0.01). "
01/01/2001 - "During the interval between the cessation of wild virus transmission and the global stoppage of polio vaccination, it will be advantageous to use IPV, particularly combined with DPT vaccine, to provide individual protection, and herd effect to prevent spread in case of the introduction of wild polioviruses, whether unintentionally or otherwise, and to bolster the Expanded Programme on Immunisation."
11/01/1993 - "The proportions of infants on whom immunisation was initiated, were very high for DPT vaccine (88-99%) and polio vaccine (85-99%); however, of those who had received the first dose, 23-39 per cent did not complete the 3-dose schedule. "
11/15/2015 - "All children were to receive OPV with pentavalent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B) at 6, 10, and 14 weeks of age. "
10/01/2014 - "The committee has reviewed and offered its recommendations on the currently available pentavalent vaccine (DTwP+Hib+Hepatitis-B) combinations in Indian market. "
08/01/2012 - "Timing of hepatitis B vaccination and impact of non-simultaneous vaccination with DTP vaccine following introduction of a hepatitis B birth dose in the Philippines."
09/01/2004 - "The immunogenic potency of vaccine "Bubo-Kok" with respect to all its components was not inferior to that of adsorbed DPT vaccine and vaccine against hepatitis B, when introduced simultaneously in different areas of the body. "
09/01/2004 - "The number of postvaccinal reactions in children aged 1 and 2 years, immunized with vaccine "Bubo-Kok", was not statistically different from those in groups of children immunized with adsorbed DPT vaccine, as well with such vaccine in combination with vaccine against hepatitis B. "
|2.||Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)
|4.||Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)
|5.||Tetanus Toxoid (Vaccine, Tetanus)
|7.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|8.||Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)
|4.||Neonatal Intensive Care